Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000929638-26-000112
Filing Date
2026-01-09
Accepted
2026-01-09 21:48:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 14040
  Complete submission text file 0000929638-26-000112.txt   15524
Mailing Address C/O VENTYX BIOSCIENCES, INC. 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address
Subramaniam Somu (Filed by) CIK: 0001508910 (see all company filings)

Type: SCHEDULE 13D/A

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 7604076511
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-92974 | Film No.: 26524480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)